Medical Second Opinion Market Research Report - Global Forecast till 2027

Medical Second Opinion Market: By Services (Medical Condition Management, Post-Acute Care Nursing, Medical Peer Review Services), Providers (Hospital Physicians/Specialties, Online Physicians Portal, Medical Second Opinion Companies, Health Insurance Companies), Application (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders, Ocular Disorders), Source of Service (In-house, Outsourced) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027.

ID: MRFR/HC/8223-HCR | February, 2021 | Region : Global

Market Forecast


Global Medical Second Opinion Market is expected to hold a value of USD 9751.58 Million by 2027 and is expected to register a growth of 15.8 % from 2020 to 2027.


Market Synopsis


A second opinion is a result of seeking an evaluation by another doctor or surgeon to confirm the diagnosis and treatment plan of the primary physician, or to offer an alternative diagnosis and/or treatment approach. High demand for the second opinion due to the outbreak of COVID 19, financial, health and legal costs involved in the treatment, increased need to improve diagnosis and treatment planning are the key factors that are expected to drive the market growth. For instance, cancer patients usually prefer medical second opinion for more information or a different treatment option or decision to avoid complications. According to the Centers for Disease Control and Prevention (CDC) 2017 US report, the number of deaths due to cancer was 5, 99,108. Thus, improvement in diagnosis and treatment can reduce the number of deaths of cancer patients. Moreover, increasing instances of medical errors, reducing financial costs of medical services and ease of interaction, and health insurance emphasizing on the second opinion for effective management of health claims are also expected to boost the market growth.


Market Influencer


The outbreak of COVID 19, leading to increased demand for the second opinion provided by physicians and health insurance providers. The physicians choose to recommend a second opinion if there is a need for better diagnosis and detection of the disease. The health insurance providers recommend a second opinion to know about the insurance coverage for various services.


Market Drivers



  • High demand for the second opinion, due to the outbreak of COVID19



  • Involvement of financial, health, and legal costs.



  • Increased need to improve diagnosis and treatment planning. According to the World Health Organization (WHO), 2018, 9.6 million people worldwide were estimated to have died from cancer. Early diagnosis and treatment planning options can focus on improving the quality of life of patients.



  • Increasing instances of medical errors. For instance, according to the Agency for Healthcare Research and Quality, lack of appropriate communication of test results and poor coordination of medication orders for transfer of care are some medical errors that require the second opinion.



  • Reduction in financial costs and ease of interaction of medical services.



  • Health insurances for effective management of health claims.


Market Restraints



  • Lack of complete medical knowledge on treatment and diagnosis for patients and inexperienced with limited perspective is one of the restraints of the medical second opinion market.



  • Changes in economic strategies in developing countries.


Segmentation


By Services



  • Medical condition management: This is the largest growing segment as patients with severe diseases require proper diagnosis with treatment plans for better improvement. Depending on the patient’s condition there are many situations in which the second opinion is valuable. If the patient has been advised that surgery is needed and wants to confirm the treatment recommendation, the service of the second opinion by medical condition management is considered.



  • Post-Acute Care Nursing: This is the fastest-growing segment. Post-acute care refers to care provided to patients recently released from the hospital and can take place in many settings including nursing homes and rehabilitation centers.



  • Medical Peer Review Services: Medical peer review is a significant process with regard to claims settlement by an insurance company. It is the peer review that determines whether the treatment provided to a patient was medically necessary and whether the claim is legitimate, for which the second opinion is required.


By Providers



  • Hospital Physicians/ Specialties: This segment is the largest growing segment due to the increasing need for improvement during diagnosis and treatment planning. Patients may choose to seek a second opinion to receive counsel from other physicians regarding their illness or course of treatment. Physicians can recommend a second opinion whenever they believe it would be helpful inpatient care.



  • Online Physicians Portal: This segment is the fastest-growing segment as interaction for medical services is gained easily through an online portal at reduced costs. These are online applications that allow patients to interact and communicate with their healthcare providers, such as physicians and hospitals for second opinions by asking questions, leaving comments, or sending email messages.



  • Medical Second Opinion companies: A second opinion from companies provide opportunities to get information from someone other than the physician who will be directing treatment, which is usually the main source of information for most patients.



  • Health Insurance Companies: Many public and private health insurance companies are trying to control surgery costs by urging and even demanding a second opinion before surgery.


By Application



  • Cancer: A second opinion helps to feel confident while receiving cancer care needed and deserved. A second opinion may reveal additional treatment options for the respective type and stage of cancer, or confirm a current treatment approach.



  • Diabetes: Healthcare providers often encourage second opinions. By consulting with different doctors can help in sorting through treatment options, answer questions, and shed new light on how diabetes is causing an effect.



  • Cardiac Disorders- A new heart disease can benefit from a cardiac second opinion. This valuable service allows us to know about diagnosis and provides information about treatment choices. A second opinion offers reassurance about treatment decisions.



  • Neurological Disorders: The neurological second opinion gives guidance to consult the respective doctors. If a patient has been diagnosed with a severe brain disease, including surgery, a second opinion can assure valuable guidance and peace of mind.



  • Respiratory Disorders: A second opinion may confirm the original diagnosis with accuracy and proper treatment plan for a respective respiratory disorder.



  • Ocular Disorders: A second opinion is often an exercise in reassurance; it may well reveal a diagnostic error. Usually, for ocular disorders, ophthalmologists are open to accepting and suggesting a second opinion when a patient needs another approach or another viewpoint.



  • Pulmonary Disorders: A type of disease that affects the lungs and other parts of the respiratory system. Pulmonary disorders include asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, pneumonia, and lung cancer. A second opinion may lead to proper diagnosis and treatment with accurate planning.



  • Nephrological Disorder: Patients with all types of renal and hypertension-related disorders receive advanced, comprehensive, and compassionate care through the second opinion.


By Source of Service



  • In-house: An in-house source of service is to have complete control of everything. When billing is managed in-house, the cost will be under control.



  • Outsourced: An outsourced service is less expensive, transparent, and consistent.


By Region



  • Americas: The largest regional market. The increasing need to improve diagnosis in the region is expected to drive the market. According to the American Cancer Society, in 2019, an estimated 17, 62,450 new cases were diagnosed with cancer. Moreover, increasing treatment planning amongst people is also expected to contribute the market growth.



  • Europe: The medical second opinion market in Europe held the second-largest position owing to increasing medical errors. According to the National Health Services (NHS), 2018, it estimated 237 million medical errors and avoidable adverse drug reactions causing hundreds of deaths. Therefore, to overcome the increase in medical errors, the region is expected to boost market growth.



  • Asia-Pacific: The fastest-growing segment due to the developing economy across the region. The medical second opinion is high in the case of chronic diseases such as diabetes and cancer. According to the World Health Organization (WHO), 2016, diabetes was the direct cause of 1.6 million deaths. By improving diagnosis in the region through the second opinion can drive the market during the forecast period.



  • Middle East and Africa: According to the World Congress of Cardiology and Cardiovascular Health, 2018, a rapid increase in cardiovascular disease burden across the region has been projected for the next decade, with corresponding increases in mortality. Hence, by improving treatment plans and diagnosis with ease of interaction among patients is expected to boost the market growth of the second opinion.


Key Players



  • SecondOpinionExpert, Inc.

  • DoctorSpring

  • 2nd MD

  • Cleveland Clinic MyConsult

  • Partners Healthcare

  • HCA Hospitals

  • Teladoc Health, Inc.

  • Amradnet

  • Johns Hopkins Medicine

  • COM.

  • Mediguide

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Medical Second Opinion Market, by Services

1.1.2. Global Medical Second Opinion Market, by Providers

1.1.3. Global Medical Second Opinion Market, by Application

1.1.4. Global Medical Second Opinion Market, by Source of Service

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Research Methodology for Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

5.3. Impact of Coronavirus (COVID-19) on Global Medical Second Opinion Market

5.3.1. Demand-Supply Analysis

5.3.2. Capital Expenditure

5.3.3. Pricing Analysis

5.3.4. Consumption Analysis

5.3.5. Impact on Key Players

5.3.6. Role of Government

6. GLOBAL MEDICAL SECOND OPINION MARKET, BY SERVICES

6.1. Overview

6.2. Medical Condition Management

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Post-Acute Care Nursing

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Medical Peer Review Services

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL MEDICAL SECOND OPINION MARKET, BY PROVIDERS

7.1. Overview

7.2. Hospitals Physicians/Specialties

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Online Physicians Portal

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Medical Second Opinion Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Health Insurance Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL MEDICAL SECOND OPINION MARKET, BY APPLICATION

8.1. Overview

8.2. Cancer

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Diabetes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Cardiac Disorders

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. Neurological Disorders

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6. Respiratory Disorders

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.7. Ocular Disorders

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICE

9.1. Overview

9.2. In-house

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3. Outsourced

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10. GLOBAL MEDICAL SECOND OPINION MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitor Dashboard

11.3. Major Growth Strategy in the Global Medical Second Opinion Market

11.4. Competitive Benchmarking

11.5. The Leading Player in terms of Number of Developments in the Global Medical Second Opinion Market

11.6. Key Developments & Growth Strategies

11.6.1. New Product Launch/Service Deployment

11.6.2. Merger & Acquisition

11.6.3. Joint Ventures

11.7. Major Players Financial Matrix & Market Ratio

11.7.1. Sales & Operating Income 2018

11.7.2. Major Players R&D Expenditure 2018

12. COMPANY PROFILES

12.1. SecondOpinionExpert, Inc.

12.1.1. Company Overview

12.1.2. Products/Services Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. DoctorSpring.

12.3. 2nd.MD

12.4. Cleveland Clinic MyConsult

12.5. Partners Healthcare

12.6. HCA Hospitals

12.7. Teladoc Health, Inc.

12.8. Amradnet

12.9. Johns Hopkins Medicine

12.10. XMRI.COM.

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

  In section 12, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

  Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.

LIST OF TABLES

TABLE 1 GLOBAL MEDICAL SECOND OPINION MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL MEDICAL SECOND OPINION MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 7 GLOBAL MEDICAL SECOND OPINION MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 10

TABLE 11 NORTH AMERICA: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 12 NORTH AMERICA: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 13 US: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 14 US: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 15 US: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 16 US: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 17 CANADA: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 18 CANADA: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 19 CANADA: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 20 CANADA: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 21 LATIN AMERICA: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 22 LATIN AMERICA: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 23 LATIN AMERICA: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 24 LATIN AMERICA: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 25 EUROPE: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 26 EUROPE: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 27 EUROPE: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 28 EUROPE: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 31

TABLE 32 WESTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 33 WESTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 36 EASTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 37 EASTERN EUROPE: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 40 ASIA-PACIFIC: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 41 ASIA-PACIFIC: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: MEDICAL SECOND OPINION MARKET, BY SERVICES, 2020–2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: MEDICAL SECOND OPINION MARKET, BY PROVIDERS, 2020–2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA: MEDICAL SECOND OPINION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA: MEDICAL SECOND OPINION MARKET, BY SOURCE OF SERVICES, 2020–2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MEDICAL SECOND OPINION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MEDICAL SECOND OPINION MARKET

FIGURE 4 GLOBAL MEDICAL SECOND OPINION MARKET SHARE, BY SERVICES, 2018 (%)

FIGURE 5 GLOBAL MEDICAL SECOND OPINION MARKET SHARE, BY PROVIDERS, 2018 (%)

FIGURE 6 GLOBAL MEDICAL SECOND OPINION MARKET SHARE, BY APPLICATION 2018 (%)

FIGURE 7 GLOBAL MEDICAL SECOND OPINION MARKET SHARE, BY SOURCE OF SERVICES, 2018 (%)

FIGURE 8 GLOBAL MEDICAL SECOND OPINION MARKET SHARE, BY REGION, 2018 (%)

FIGURE 9 AMERICAS: MEDICAL SECOND OPINION MARKET SHARE BY REGION, 2018 (%)

FIGURE 10 NORTH AMERICA: MEDICAL SECOND OPINION MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 11 EUROPE: MEDICAL SECOND OPINION MARKET SHARE, BY REGION, 2018 (%)

FIGURE 12 WESTERN EUROPE: MEDICAL SECOND OPINION MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 13 ASIA-PACIFIC: MEDICAL SECOND OPINION MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 14 MIDDLE EAST & AFRICA: MEDICAL SECOND OPINION MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 15 GLOBAL MEDICAL SECOND OPINION MARKET: COMPANY SHARE ANALYSIS, 2018 (%)

FIGURE 16 SECONDOPINIONEXPERT, INC: KEY FINANCIALS

FIGURE 17 SECONDOPINIONEXPERT, INC: SEGMENTAL REVENUE

FIGURE 18 SECONDOPINIONEXPERT, INC: REGIONAL REVENUE

FIGURE 19 DOCTORSPRING. : KEY FINANCIALS

FIGURE 20 DOCTORSPRING. .: SEGMENTAL REVENUE

FIGURE 21 DOCTORSPRING. : REGIONAL REVENUE

FIGURE 22 2ND.MD: KEY FINANCIALS

FIGURE 23 2ND.MD: SEGMENTAL REVENUE

FIGURE 24 2ND.MD: REGIONAL REVENUE

FIGURE 25 CLEVELAND CLINIC MYCONSULT: KEY FINANCIALS

FIGURE 26 CLEVELAND CLINIC MYCONSULT: SEGMENTAL REVENUE

FIGURE 27 CLEVELAND CLINIC MYCONSULT: REGIONAL REVENUE

FIGURE 28 PARTNERS HEALTHCARE: KEY FINANCIALS

FIGURE 29 PARTNERS HEALTHCARE: SEGMENTAL REVENUE

FIGURE 30 PARTNERS HEALTHCARE: REGIONAL REVENUE

FIGURE 31 HCA HOSPITALS: KEY FINANCIALS

FIGURE 32 HCA HOSPITALS: SEGMENTAL REVENUE

FIGURE 33 HCA HOSPITALS: REGIONAL REVENUE

FIGURE 34 TELADOC HEALTH, INC.: KEY FINANCIALS

FIGURE 35 TELADOC HEALTH, INC.: SEGMENTAL REVENUE

FIGURE 36 TELADOC HEALTH, INC.: REGIONAL REVENUE

FIGURE 37 AMRADNET: KEY FINANCIALS

FIGURE 38 AMRADNET: SEGMENTAL REVENUE

FIGURE 39 AMRADNET: REGIONAL REVENUE

FIGURE 40 JOHNS HOPKINS MEDICINE: KEY FINANCIALS

FIGURE 41 JOHNS HOPKINS MEDICINE: SEGMENTAL REVENUE

FIGURE 42 JOHNS HOPKINS MEDICINE: REGIONAL REVENUE

FIGURE 43 XMRI.COM.: KEY FINANCIALS

FIGURE 44 XMRI.COM.: SEGMENTAL REVENUE

FIGURE 45 XMRI.COM: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.